- Clinical Trials
- December 2021
- 270 Pages
Global
From €2409EUR$2,500USD£2,072GBP
- Clinical Trials
- December 2021
- 93 Pages
Global
From €2409EUR$2,500USD£2,072GBP
- Clinical Trials
- December 2021
- 98 Pages
Global
From €2409EUR$2,500USD£2,072GBP
- Clinical Trials
- December 2021
- 295 Pages
Global
From €2409EUR$2,500USD£2,072GBP
- Drug Pipelines
- March 2021
Global
From €1927EUR$2,000USD£1,658GBP
- Drug Pipelines
- March 2021
Global
From €1927EUR$2,000USD£1,658GBP
- Drug Pipelines
- November 2020
- 1251 Pages
Global
From €2409EUR$2,500USD£2,072GBP
- Drug Pipelines
- November 2020
- 733 Pages
Global
From €2409EUR$2,500USD£2,072GBP
- Drug Pipelines
- November 2020
- 358 Pages
Global
From €1927EUR$2,000USD£1,658GBP
- Drug Pipelines
- November 2020
- 190 Pages
Global
From €1927EUR$2,000USD£1,658GBP
- Drug Pipelines
- October 2020
- 375 Pages
Global
From €1927EUR$2,000USD£1,658GBP
- Drug Pipelines
- October 2020
- 89 Pages
Global
From €3373EUR$3,500USD£2,901GBP
- Drug Pipelines
- September 2020
- 57 Pages
Global
From €1927EUR$2,000USD£1,658GBP
- Drug Pipelines
- August 2020
- 269 Pages
Global
From €1927EUR$2,000USD£1,658GBP
- Drug Pipelines
- July 2020
- 80 Pages
Global
From €1927EUR$2,000USD£1,658GBP
- Drug Pipelines
- July 2020
- 52 Pages
Global
From €1927EUR$2,000USD£1,658GBP
- Drug Pipelines
- July 2020
- 87 Pages
Global
From €1927EUR$2,000USD£1,658GBP
- Drug Pipelines
- July 2020
- 241 Pages
Global
From €1927EUR$2,000USD£1,658GBP
- Drug Pipelines
- July 2020
- 97 Pages
Global
From €1927EUR$2,000USD£1,658GBP
- Drug Pipelines
- June 2020
- 35 Pages
Global
From €1927EUR$2,000USD£1,658GBP
The Metabolic Disorder Drug market is a subset of the Endocrine and Metabolic Disorders Drugs market. It includes drugs used to treat metabolic disorders such as diabetes, obesity, and hyperlipidemia. These drugs are used to regulate the body's metabolism, which is the process of converting food into energy. Common drugs used to treat metabolic disorders include insulin, sulfonylureas, biguanides, thiazolidinediones, and GLP-1 agonists. These drugs are used to control blood sugar levels, reduce cholesterol, and promote weight loss.
The Metabolic Disorder Drug market is highly competitive, with many companies offering a variety of drugs to treat metabolic disorders. Some of the major players in the market include Novo Nordisk, Sanofi, Eli Lilly, Merck, and AstraZeneca. Other companies in the market include Boehringer Ingelheim, Takeda, and Pfizer. Show Less Read more